World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

Shanghai Industrial Holdings is a conglomerate company with three core businesses and they are infrastructure facilities (including toll roads/bridge, and environmental protection related business such as sewage treatment and solid waste treatment business), real estate and consumer products (including Nanyang Tobacco and Wing Fat Printing). The company annual revenue is 38,747 million HKD and annual net income is 3,745 million HKD for year ending Dec-2021. The headquarters is in Hong Kong.

CanSino Biologics is an Innovative Biopharmaceutical company. It is currently developing 16 vaccine candidates for 13 infectious disease areas, preventing meningitis, pneumonia, tuberculosis, COVID-19, Ebola virus disease, pertussis, diphtheria, tetanus, shingles etc. The headquarters is in China.

Perrigo is a leading global healthcare company, focused on providing value to its customers and consumers by delivering Quality Affordable Healthcare Products. Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. Perrigo is the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market.

Constellation Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company using expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression.

Syndax Pharmaceuticals is a Clinical Stage Biopharmaceutical company developing an innovative pipeline of cancer therapies. The company annual revenue is 1.5 million USD and 38 employees as on 2019. The headquarters is in USA.

TSUMURA & CO is a Pharmaceutical company focused on Raw Materials for Crude Drug. The company annual revenue is 130,881 million JPY and annual net income is 15,332 million JPY as on 2021. The headquarters is in Japan.

ANI Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is focused on delivering value to customers by developing, manufacturing and marketing high quality branded and generic prescription pharmaceuticals. The company annual revenue is 206.5 million USD and 338 employees as on 2019. The headquarters is in USA.